Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
about
Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Physiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIV.Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents.Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.
P2860
Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
description
im September 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2013
@uk
name
Physiologically based pharmaco ...... rogress and future perspective
@en
Physiologically based pharmaco ...... rogress and future perspective
@nl
type
label
Physiologically based pharmaco ...... rogress and future perspective
@en
Physiologically based pharmaco ...... rogress and future perspective
@nl
prefLabel
Physiologically based pharmaco ...... rogress and future perspective
@en
Physiologically based pharmaco ...... rogress and future perspective
@nl
P2860
P50
P356
P1433
P1476
Physiologically based pharmaco ...... rogress and future perspective
@en
P2093
Paul Curley
P2860
P304
P356
10.2217/FVL.13.67
P577
2013-09-01T00:00:00Z